Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Xtant Medical Hldgs Q2 EPS $(0.02), Inline, Sales $20.23M Beat $19.50M Estimate

Author: Benzinga Newsdesk | August 01, 2023 07:06am

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $20.23 million which beat the analyst consensus estimate of $19.50 million by 3.75 percent. This is a 32.43 percent increase over sales of $15.28 million the same period last year.

Posted In: XTNT